Prostate Cancer

Roedd y cais yn rhannol lwyddiannus.

Dear Surrey and Sussex Healthcare NHS Trust,

I would like to please request the following information.

1. In the most recent 12 months of data which you have access to, how many patients have been diagnosed with the following stages of prostate cancer:
A) Stage 1 and stage 2 - localised prostate cancer
B) Stage 3 cancer that has not spread to other parts of the body - locally advanced prostate cancer
C) Stage 4 cancer which has spread to other parts of the body - metastatic prostate cancer.

2. In reference to the answer for question 1:

A) what number, for each stage, received novel imaging?
B) what was the average, for each stage, time post diagnosis for them to receive the novel imaging?

3. In the most recent 12 months of data which you have access to, how many patients in total initially sat within the urology department, but were referred to the oncology department before they develop metastases?

4. In reference to the answer for question 3, what number of these patients developed metastases prior to being referred to the oncology department.

5. For all patients who have received darolutamide, what is the average duration of treatment?

Thank you for taking the time to answer these questions.

Yours faithfully,

Oliver Caswell

FOI (SURREY AND SUSSEX HEALTHCARE NHS TRUST), Surrey and Sussex Healthcare NHS Trust

1 Atodiad

Dear Oliver,

 

Thank you for your request for information which is now being handled
under the terms of the Freedom of Information Act 2000.

 

Your request is receiving attention and we will provide a response within
20 working days, that is, by 23 November 2022.

 

Please contact me if you have any queries in the interim, quoting our
reference (FOI 7243)  and I will be happy to help.

 

Kind regards,

 

Jeanette

 

 

Jeanette Randall
Freedom of information officer and communications support
Communications and marketing
Surrey and Sussex Healthcare NHS Trust
East Surrey Hospital, Redhill, RH1 5RH​

[1][Surrey and Sussex Healthcare NHS Trust request email]
[2]www.surreyandsussex.nhs.uk

 

Please note: I work remotely on Mondays and Fridays and Wednesday is my
non-working day

 

One Team l Compassion l Dignity and Respect l Safety and Quality

[3]cid:image004.png@01D71C18.3931D940

Follow us on social media: [4]Twitter ¦ [5]Facebook ¦ [6]LinkedIn ¦
[7]YouTube

 

 

 

 

 

dangos adrannau a ddyfynnir

FOI (SURREY AND SUSSEX HEALTHCARE NHS TRUST), Surrey and Sussex Healthcare NHS Trust

1 Atodiad

Dear Oliver

 

Thank you for your email requesting information about prostate cancer.

 

From our preliminary assessment, we note we need further clarification and
information in order to identify and locate the information you have asked
for and to be able to answer your enquiry.

 

Please clarify your questions in consideration of the points below:

 

• What is novel imaging?

 

Once we have clarification of your request from you, I will be able to
continue to process your request.  If I do not receive clarification
within two months your request will be considered to have lapsed. (Under
section 1(3) of the Freedom of Information Act (FOIA), a public authority
need not comply with a request unless any further information reasonably
required to locate the information is supplied).

 

Please remember to quote the reference 7243 in any future communications.

 

Kind regards

 

Jeanette

 

Jeanette Randall
Freedom of information officer and communications support
Communications and marketing
Surrey and Sussex Healthcare NHS Trust
East Surrey Hospital, Redhill, RH1 5RH​

[1][Surrey and Sussex Healthcare NHS Trust request email]
[2]www.surreyandsussex.nhs.uk

 

Please note: I work remotely on Mondays and Fridays and Wednesday is my
non-working day

 

One Team l Compassion l Dignity and Respect l Safety and Quality

[3]cid:image004.png@01D71C18.3931D940

Follow us on social media: [4]Twitter ¦ [5]Facebook ¦ [6]LinkedIn ¦
[7]YouTube

 

 

 

 

 

 

dangos adrannau a ddyfynnir

Dear FOI (SURREY AND SUSSEX HEALTHCARE NHS TRUST),

Thank you for your email. To clarify, I am looking for data relating to newer imaging modalities, in particular PSMA-PET/CT.
This consists of Prostate-specific membrane antigen PSMA which is a cell surface enzyme that is highly expressed in prostate cancer, several PET agents have been developed to bind to PSMA and serve as tracers for PET/CT.

Yours sincerely,

Oliver Caswell

FOI (SURREY AND SUSSEX HEALTHCARE NHS TRUST), Surrey and Sussex Healthcare NHS Trust

2 Atodiad

Dear Oliver,

 

Please see attached our response to your Freedom of Information request.

 

Kind regards,

Jeanette

 

 

Jeanette Randall
Freedom of information officer and communications support
Communications and marketing
Surrey and Sussex Healthcare NHS Trust
East Surrey Hospital, Redhill, RH1 5RH​

[1][Surrey and Sussex Healthcare NHS Trust request email]
[2]www.surreyandsussex.nhs.uk

 

Please note: I work remotely on Mondays and Fridays and Wednesday is my
non-working day

 

One Team l Compassion l Dignity and Respect l Safety and Quality

[3]cid:image004.png@01D71C18.3931D940

Follow us on social media: [4]Twitter ¦ [5]Facebook ¦ [6]LinkedIn ¦
[7]YouTube

 

 

 

 

 

dangos adrannau a ddyfynnir